Longitudinal Assessment of Enhancing Foci of Abnormal Signal Intensity in Neurofibromatosis Type 1.
Nicolin HaincMatthias W WagnerSuzanne LaughlinJames T RutkaCynthia HawkinsSusan I BlaserBirgit Betina Ertl-WagnerPublished in: AJNR. American journal of neuroradiology (2021)
Albeit very rare, contrast-enhancing lesions in patients with neurofibromatosis 1 may regress over time. Follow-up MR imaging aids in ascertaining regression. The development of atypical features should prompt further evaluation for underlying tumors.